PharmaCyte Biotech, Inc. (PMCB) Q3 2025 Annual Earnings

Screener

Reported September 15, 2025 · Before market open

EPS-$0.09

Next report

Dec 16, 2026 (in a month)

EPS estimate-$0.06

Versus estimates

Diluted EPS

Q3 2026-$0.54Miss by $0.48 Q2 2026-$0.54Miss by $0.48 Q1 2026$0.13Beat by $0.19 Q4 2025-$0.32

Q3 2025-$0.09

FAQ

When did PharmaCyte Biotech, Inc. report Q3 2025 earnings?: PharmaCyte Biotech, Inc. (PMCB) reported Q3 2025 earnings on September 15, 2025 before market open.
What were PharmaCyte Biotech, Inc.'s Q3 2025 revenue and EPS?: PharmaCyte Biotech, Inc. reported eps of $-0.09 for Q3 2025.
Where can I find PharmaCyte Biotech, Inc.'s Q3 2025 SEC filings?: You can read the 10-K periodic report (0001683168-25-005821) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment PharmaCyte Biotech, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk